.@realDonaldTrump on the need for PBM transparency & accountability: “We’re going to reduce prices, because the middleman makes more money than the drug companies. There's a middleman that nobody even knows who they are."
Altering IP laws could harm Indiana’s leadership in life sciences research and innovation. @SenatorBraun, Hoosier life science companies and patients alike need policies that support, not stifle, breakthrough treatments!
The Hatch-Waxman Act ensures #biopharma companies can invest in groundbreaking research while creating a pathway for affordable generics. As we approach the law’s 40th anniversary, let’s reflect on the great balance of innovation and access. https://t.co/1ReX1aONIq
For more than a decade, @RepLarryBucshon has served Hoosiers and all Americans by advocating for patient-centered healthcare in Congress. His leadership on the #340B ACCESS Act will ensure the program adequately supports safety-net providers’ efforts and prioritizes accessibility
We’re grateful for the leadership of @RepLarryBuschon on #340BReform and putting patients over profits. H.R.8574 will make essential changes to this vital program to ensure health centers can provide low-income patients with effective medication at affordable prices.
Thank you, @RepLarryBucshon! H.R.8574 will help ensure the #340B continues to work the way it was originally meant to. Your leadership on this legislation will help aid vulnerable communities in getting the important care they need.
Cardiovascular disease is a leading public health crisis. Thank you @SenatorBraun for advocating for seniors this #AmericanHeartMonth and highlighting gaps contributing to recurrent cardiac events due to lack of LDL-C screening. ❤️
LDL is a big risk factor for heart disease. Yet fewer than 30% of Medicare heart attack patients get LDL-C tested within 3 mos. after hospital discharge. Thank you @SenatorBraun for advocating for seniors in your recent letter to @USGAO.
BPAG Principal @rogerh is president of the board of directors of the @IHIF1 and participated in presenting Governor Holcomb with the BIO 2023 Governor of the Year Award. ⬇⬇
Everyone’s focus is on this drug list, but what about the Hoosier patients who could lose access to as many as 235 new medicines and the over 38,000 Hoosiers who could lose their jobs in the next decade based on recent research? #FixIRA#DrugPricing https://t.co/yYMOHSHEUf
The #MCED Screening Coverage Act was just reintroduced in the U.S. Senate. We urge passage this year to provide seniors access to live-saving early detection technology. https://t.co/enUcG1YnMG @SenToddYoung @SenatorBraun
Hoosiers rely on Indiana’s #biopharma industry, but new research suggests that more than 38,000 jobs across our state’s economy would be lost under expanded government-mandated #drugpricing policies. Learn more: https://t.co/zHGzb6G7Ox
Adipo Therapeutics has developed a treatment for millions who struggle with weight loss and blood glucose control.
Read more: Boosting Brown Fat to Combat Obesity and Type 2 Diabetes via @MarketWatch: https://t.co/Hg1waMPg7T
#diabetes#innovation#startup